The Labmatrix® Clinical Trial Sample and Consent Tracking (CTST) system is a configurable and upgradable system that provides comprehensive sample lifecycle support for in-study sample and sample consent management and tracking, including future-use virtual or physical biorepositories (next generation biobanking) and data mining. Utilized in more than 1,000 trials to date, Labmatrix® offers sample-centric monitoring across a clinical trial’s entire ecosystem.
Related Insights
Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials
Labmatrix®
Tracking clinical trial samples and consents to support total sample lifecycle management
Consent Tracking for Clinical Trial Samples
Optimizing the management of consents throughout the entire lifecycle
Tracking Clinical Trial Samples
Optimizing the management of samples throughout the entire lifecycle
Blockchain in Clinical Research Sample Management
Distributed Ledger Technology (DLT) in clinical trials
Managing Sample Data from Vendors
Best Practices for Clinical Trials
Using Labmatrix® at a Big Biopharma Company to Reduce Clinical Trial Delays, Costs and Regulatory Risks
Managing Sample Data from Vendors
Best practices for clinical trials
eConsent and BioBanking
How to reduce costs while improving efficiencies
Key Central Laboratory Capabilities to Enable Successful Immuno-Oncology Clinical Development
Trends and recommendations in laboratory selection
